Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor Use in Practice

What are the latest advances shaping chronic lymphocytic leukemia (CLL) treatment today? Discover the role of Bruton tyrosine kinase (BTK) inhibitors through our expert-led journey. Credit available for this activity expires: 5/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001127?ecd=bdc_podcast_libsyn_mscpedu